Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Targeting Rare Diseases

Posted on March 20th, 2017 by in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

How Bioinformatics is Boosting Precision Medicine

Posted on January 9th, 2017 by in Pharma R&D

Although the pharmaceutical industry has invested a great deal in data-producing technologies (e.g. next-generation and single cell sequencing), it has been slower to invest in the data management and analytics technologies Continue reading “How Bioinformatics is Boosting Precision Medicine” »

“Own Goals”: the price is higher than you might think

Posted on December 28th, 2016 by in Pharma R&D

As a professional, giving points away, or being involved in an “own goal,” must be quite an emotional roller coaster. However, in professional sports, the individual needs to get on with the game, put the error behind them, and move on to deal with the immediate situation. Continue reading ““Own Goals”: the price is higher than you might think” »

Top questions on the minds of QPPV

Posted on December 21st, 2016 by in Pharmacovigilance

The 2016 Pharmacovigilance Days (PHV Day 2016) kicked off in early April 2016 in Berlin, Germany. Afterwards, the tour continued to Amsterdam, London, Copenhagen, Rome and Paris in October and November. With the objective of bringing together safety experts from the pharmaceutical and healthcare industry Continue reading “Top questions on the minds of QPPV” »

  1. 1
  2. 2
  3. 3